Agios CMO exercises RSUs, sells shares for taxes
Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens reported routine equity compensation activity and related tax sales.
Rhea-AI Filing Summary
Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens reported routine equity compensation activity and related tax sales. On July 1, 2026, 8,375 restricted stock units converted into an equal number of common shares as part of a scheduled vesting from a July 1, 2023 grant.
To cover tax withholding from this vesting, 4,007 common shares were sold at $37.56 per share under durable automatic sale instructions designed to qualify for the Rule 10b5-1(c) affirmative defense. After these transactions, Gheuens directly holds 84,645 shares of Agios common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Gheuens Sarah
Role
Chief Medical Officer
Sold
4,007 shs ($151K)
Approx. gross sale proceeds
$151K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 8,375 | $0.00 | $0.00 |
| Exercise | Common stock | 8,375 | $0.00 | $0.00 |
| Sale | Common stock | 4,007 | $37.56 | $151K |
Holdings After Transaction:
Restricted stock units — 0 contracts (Direct);
Common stock — 84,645 shares (Direct)
Footnotes (3)
- F1. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated July 1, 2023.
- F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F3. The restricted stock units were granted on July 1, 2023. Beginning on July 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Key Figures
Shares sold: 4,007 shares
Sale price: $37.56 per share
RSUs converted: 8,375 units
+2 more
5 metrics
Shares sold
4,007 shares
Open-market sale on July 1, 2026 to cover tax withholding
Sale price
$37.56 per share
Price for 4,007 common shares sold on July 1, 2026
RSUs converted
8,375 units
Restricted stock units converted into common stock on July 1, 2026
Shares owned after
84,645 shares
Direct Agios common stock holdings following the reported transactions
Grant date
July 1, 2023
Date the restricted stock units were originally granted
Key Terms
restricted stock units, durable automatic sale instructions, Rule 10b5-1(c), Section 10(b) of the Securities Exchange Act of 1934, +1 more
5 terms
restricted stock units financial
"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
durable automatic sale instructions financial
"This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense..."
Rule 10b5-1(c) regulatory
"consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c)..."
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
Section 10(b) of the Securities Exchange Act of 1934 regulatory
"affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c)..."
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Agios (AGIO) Chief Medical Officer Sarah Gheuens report in this Form 4?
Sarah Gheuens reported vesting of 8,375 restricted stock units that converted into common shares, plus a related tax sale of 4,007 shares. These transactions reflect scheduled equity compensation events rather than discretionary open-market buying activity.
What are the vesting terms of Sarah Gheuens’ Agios (AGIO) restricted stock units?
Her restricted stock units were granted on July 1, 2023. Starting July 1, 2024, the underlying shares vest in three equal annual installments, with each unit representing a contingent right to receive one share of Agios common stock upon vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
